AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Atea Pharmaceuticals, Inc. Director's Dealing 2025

Feb 25, 2025

33577_dirs_2025-02-24_5bfac35a-bce6-4720-8d7c-aef44478f023.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2025-02-20

Reporting Person: Kirsch Arthur S (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	35710	Direct
Common Stock	10000	Indirect